4.5 Article

Does bariatric surgery change olfactory perception? Results of the early postoperative course

期刊

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
卷 29, 期 2, 页码 253-260

出版社

SPRINGER
DOI: 10.1007/s00384-013-1795-5

关键词

Bariatric surgery; Olfaction; TDI score; Sniffing sticks; Olfactory perception

资金

  1. Medical Research Council [G0902002] Funding Source: Medline
  2. MRC [G0902002] Funding Source: UKRI
  3. Medical Research Council [G0902002] Funding Source: researchfish

向作者/读者索取更多资源

Purpose Changes of food preference toward foods with low caloric density have been demonstrated after bariatric surgery and may contribute to sustained body weight loss. It has been hypothesized that olfactory perception as an integral part of food selection might be altered after bariatric surgery. Methods Sniffin' Sticks (R) were used to investigate the olfactory perception of morbidly obese patients undergoing either Roux-en-Y gastric bypass (RYGB, n = 15) or sleeve gastrectomy (SG, n = 15) before 1, 6, 12, and 24 weeks after surgery. Obese patients without surgical intervention served as controls (CG, n = 12). Results are presented using the testing odor threshold, discrimination, and identification score (TDI; higher scores indicate better olfactory perception). Body weight loss was recorded. Results Initial BMI of the SG group (56.04 +/- 7.096 kg m(-2)) was higher compared to the BMI of the RYGB (48.71 +/- 6.49 kg m(-2)) and CG (50.35 +/- 6.78 kg m(-2)); p = 0.011. Body weight loss among the surgical groups was not different (p = 0.011) while controls did not lose weight. Mean baseline TDI scores were significantly lower in the SG group 27.1 +/- 3.9 vs. 32.6 +/- 3.6 (RYGB) and 32.1 +/- 5.3 (CG), respectively, whereas there were after 24 weeks no changes in RYGB and CG patients; the TDI score in the SG group increased significantly to 31.1 +/- 3.5 (p < 0.01). Conclusions Our data suggest that a substantial body weight loss per se does not affect olfactory perception. However, our results point towards improved olfactory perception after sleeve gastrectomy but not Roux-en-Y gastric bypass.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma

Otilia Kimpel, Paul Schindler, Laura Schmidt-Pennington, Barbara Altieri, Felix Megerle, Harm Haak, James Pittaway, Ulrich Dischinger, Marcus Quinkler, Knut Mai, Matthias Kroiss, Buelent Polat, Martin Fassnacht

Summary: This study retrospectively analyzed all patients who received radiotherapy for advanced adrenocortical carcinoma in five European centers since 2000. The results showed that radiotherapy is effective in adrenocortical carcinoma, and higher doses of radiotherapy are associated with longer time to progression of the treated lesion. The toxicity of radiotherapy was generally mild, and no clear predictive factors could be established.

BRITISH JOURNAL OF CANCER (2023)

Article Medical Laboratory Technology

In Situ Metabolomics of Cortisol-Producing Adenomas

Masanori Murakami, Na Sun, Fengxia Li, Annette Feuchtinger, Celso Gomez-Sanchez, Martin Fassnacht, Martin Reincke, Irina Bancos, Axel Walch, Matthias Kroiss, Felix Beuschlein

Summary: Recent advances in omics techniques have allowed detailed genetic characterization of cortisol-producing adrenal adenoma (CPA). The current study conducted a comprehensive mass spectrometry imaging (MSI) map of CPAs in relation to clinical phenotypes and immunohistochemical profiles of steroidogenic enzymes. The results revealed novel metabolic links between endocrine function and tumorigenesis, which will further support the understanding of CPA pathophysiology.

CLINICAL CHEMISTRY (2023)

Article Endocrinology & Metabolism

Bariatric-metabolic surgery for NHS patients with type 2 diabetes in the United Kingdom National Bariatric Surgery Registry

Andrew Currie, Roel Bolckmans, Alan Askari, James Byrne, Ahmed R. Ahmed, Rachel L. Batterham, Kamal Mahawar, Alexander Dimitri Miras, Chris M. Pring, Peter K. Small, Richard Welbourn

Summary: This study analyzed the baseline characteristics, disease severity, and operations performed on people with obesity and T2DM undergoing bariatric-metabolic surgery in the NHS. The study found that bariatric-metabolic surgery is used for people with T2DM much later in the disease process when it is less effective. National guidance and data from RCTs have had little impact on clinical practice.

DIABETIC MEDICINE (2023)

Review Oncology

Diagnosis and management of parathyroid carcinoma: a state-of-the-art review

Pia Roser, Bianca M. Leca, Claudia Coelho, Klaus-Martin Schulte, Jackie Gilbert, Eftychia E. Drakou, Christos Kosmas, Ling Ling Chuah, Husam Wassati, Alexander D. Miras, James Crane, Simon J. B. Aylwin, Ashley B. Grossman, Georgios K. Dimitriadis

Summary: Parathyroid carcinoma is a rare endocrine malignancy, accounting for about 1% of primary hyperparathyroidism cases. A systematic review of literature was conducted to analyze data on parathyroid carcinoma patients, including molecular pathogenesis, clinical presentation, treatment, and overall survival. The review included 75 studies from 17 countries, covering over 3000 patients. CDC73 mutation plays a pivotal role in the molecular pathogenesis of parathyroid carcinoma. En bloc resection is the recommended surgical approach, and targeted therapy based on molecular biomarkers shows promise as a novel treatment option.

ENDOCRINE-RELATED CANCER (2023)

Article Endocrinology & Metabolism

Volume-outcome relationship in adrenal surgery from 2009-2017 in Germany-a retrospective study

Konstantin L. Uttinger, Joachim Reibetanz, Johannes Diers, Philip Baum, Sebastian Pietryga, Anne Hendricks, Leon Schuetze, Nikolas Baumann, Verena Wiegering, Johann Lock, Ulrich Dischinger, Florian Seyfried, Martin Fassnacht, Christoph-Thomas Germer, Armin Wiegering

Summary: The annual caseload of adrenal resections varies among German hospitals. Surgery in high-volume centers is associated with better patient outcomes, although fatal complications are rare.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2023)

Article Biochemistry & Molecular Biology

Changes in Plasma Metabolomic Profile Following Bariatric Surgery, Lifestyle Intervention or Diet Restriction-Insights from Human and Rat Studies

Ilja Balonov, Max Kurlbaum, Ann-Cathrin Koschker, Christine Stier, Martin Fassnacht, Ulrich Dischinger

Summary: Although the metabolic changes caused by bariatric surgery are known, it is unclear if these changes are specific to the surgery itself or a result of weight loss. A study using liquid chromatography tandem mass spectrometry found that Roux-en-Y Gastric Bypass (RYGB) surgery resulted in distinct changes in the metabolome, which were different from those observed in non-surgical intervention groups.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Endocrinology & Metabolism

Hypothalamic integrity is necessary for sustained weight loss after bariatric surgery: A prospective, cross-sectional study

Ulrich Dischinger, Laura Kotzner, Petia Kovatcheva-Datchary, Helena Kleinschmidt, Christina Haas, Jose Perez, Cornelius Presek, Ann-Cathrin Koschker, Alexander D. Miras, Mohammed K. Hankir, Christoph-Thomas Germer, Martin Fassnacht, Martin J. Herrmann, Florian Seyfried, Jorg Vogel

Summary: Hypothalamic integrity is necessary for the effectiveness of bariatric surgery in humans. Peripheral changes after bariatric surgery are not sufficient to induce satiety and long-term weight loss in patients with hypothalamic damage.

METABOLISM-CLINICAL AND EXPERIMENTAL (2023)

Review Endocrinology & Metabolism

The efficacy of GLP-1RAs for the management of postprandial hypoglycemia following bariatric surgery: a systematic review

David C. C. Llewellyn, Hugh Logan Ellis, Simon J. B. Aylwin, Eduard Ostarijas, Shauna Green, William Sheridan, Nicholas W. S. Chew, Carel W. W. le Roux, Alexander D. D. Miras, Ameet G. G. Patel, Royce P. P. Vincent, Georgios K. K. Dimitriadis

Summary: Postprandial hyperinsulinemic hypoglycemia with neuroglycopenia is a recognized complication of bariatric surgery. This systematic review suggests that GLP-1 receptor agonists (GLP-1RAs) may reduce the number of postprandial hypoglycemic episodes and improve glycemic variability.

OBESITY (2023)

Article Endocrinology & Metabolism

Tripeptide gut hormone infusion does not alter food preferences or sweet taste function in volunteers with obesity and prediabetes/diabetes but promotes restraint eating: A secondary analysis of a randomized single-blind placebo-controlled study

Preeshila Behary, Haya Alessimii, Alexander D. Miras, George Tharakan, Kleopatra Alexiadou, Madhawi M. Aldhwayan, Sanjay Purkayastha, Krishna Moorthy, Ahmed R. Ahmed, Stephen R. Bloom, Tricia M. Tan

Summary: This study aimed to investigate whether the elevation in postprandial concentrations of gut hormones accounts for the beneficial changes in food preferences, sweet taste function, and eating behavior after Roux-en-Y gastric bypass (RYGB). A randomized single-blind study was conducted, where GLP-1, OXM, PYY (GOP) or saline was infused for 4 weeks in subjects with obesity and prediabetes/diabetes. The results showed that GOP treatment reduced daily energy intake by 27% and restraint eating was significantly reduced, but no significant changes in food preferences, sweet taste function, and consummatory reward value of sweet taste were observed.

DIABETES OBESITY & METABOLISM (2023)

Article Endocrinology & Metabolism

Bilateral inferior petrosal sinus sampling with human CRH stimulation in ACTH-dependent Cushing's syndrome: results from a retrospective multicenter study

Mario Detomas, Katrin Ritzel, Isabella Nasi-Kordhishti, Marie Helene Schernthaner-Reiter, Marco Losa, Viola Troeger, Barbara Altieri, Matthias Kroiss, Ralph Kickuth, Martin Fassnacht, Alexander Micko, Juergen Honegger, Martin Reincke, Timo Deutschbein

Summary: This multicenter study confirmed the diagnostic accuracy of BIPSS in differentiating between CD and ECS. It also suggests that measuring prolactin levels may further improve the diagnostic performance of this test.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2023)

Review Medicine, General & Internal

The implications of defining obesity as a disease: a report from the Association for the Study of Obesity 2021 annual conference

Migena Luli, Giles Yeo, Emma Farrell, Jane Ogden, Helen Parretti, Emma Frew, Stephen Bevan, Adrian Brown, Jennifer Logue, Vinod Menon, Nadya Isack, Michael Lean, Chris McEwan, Paul Gately, Simon Williams, Nerys Astbury, Maria Bryant, Kenneth Clare, Georgios K. Dimitriadis, Graham Finlayson, Nicola Heslehurst, Brett Johnson, Sarah Le Brocq, Audrey Roberts, Patrick McGinley, Julia Mueller, Mary O'Kane, Rachel L. Batterham, Kath Roberts, Alexander Dimitri Miras

Summary: This report discusses the potential impact of defining obesity as a disease on various aspects including patients, healthcare system, economy, and society. Speakers from different disciplines provided their viewpoints and expertise, aiming to explore the implications and gaps in data. The common goal is to provide a healthcare system that supports and protects patients, strategies that protect the economy and society, and policies that reduce stigma and promote health equity.

ECLINICALMEDICINE (2023)

Review Endocrinology & Metabolism

Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis

Iris C. M. Pelsma, Martin Fassnacht, Stylianos Tsagarakis, Massimo Terzolo, Antoine Tabarin, Anju Sahdev, John Newell-Price, Ljiljana Marina, Kerstin Lorenz, Irina Bancos, Wiebke Arlt, Olaf M. Dekkers

Summary: This systematic review and meta-analysis found that patients with adrenal incidentalomas and mild autonomous cortisol secretion (MACS) have a higher prevalence of comorbidities such as diabetes, hypertension, and dyslipidemia, as well as increased all-cause mortality. Adrenalectomy appears to improve glucometabolic control, hypertension, and dyslipidemia in patients with MACS.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2023)

Article Endocrinology & Metabolism

Asymmetric Adrenals: Sexual Dimorphism of Adrenal Tumors

Nicole Bechmann, Mats Leif Moskopp, Georgiana Constantinescu, Anthony Stell, Angela Ernst, Frank Berthold, Frank Westermann, Jingjing Jiang, Longfei Lui, Elisabeth Nowak, Stephanie Zopp, Karel Pacak, Mirko Peitzsch, Andreas Schedl, Martin Reincke, Felix Beuschlein, Stefan R. Bornstein, Martin Fassnacht, Graeme Eisenhofer, Int Network Adrenal Tumours

Summary: This study investigated the occurrence of adrenal tumors in relation to sex and adrenal asymmetry. It was found that females were more prone to adrenal cortical carcinoma, aldosterone-producing adenoma, and cortisol-secreting adrenocortical adenomas, while males were more prone to pheochromocytoma. Adrenal tumors were more commonly located on the left side, except for pheochromocytoma which was more commonly on the right. Additionally, females had smaller adrenals compared to males.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Article Endocrinology & Metabolism

Corticotropin-releasing hormone test predicts the outcome of unilateral adrenalectomy in primary bilateral macronodular adrenal hyperplasia

I. Tizianel, M. Detomas, T. Deutschbein, M. Fassnacht, N. Albiger, M. Iacobone, C. Scaroni, F. Ceccato

Summary: Unilateral adrenalectomy is an effective alternative treatment for PBMAH, achieving surgical cure in three out of four patients. Pre-operative hCRH testing can predict long-term remission rates.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2023)

Article Surgery

Pharmacotherapy of obesity-Competition to bariatric surgery or a meaningful supplement?

Tina Mazaheri, Saleem Ansari, Madhavi Nallagonda, Lars Kollmann, Felix Nickel, Florian Seyfried, Alexander Dimitri Miras

Summary: Obesity requires a long-term multimodal approach, starting with lifestyle intervention and potentially combining medication and surgery. This article provides an overview of conservative medicinal treatment regimens, approved medications, and ongoing studies, emphasizing the importance of combination treatment. Data suggests that a multimodal approach can lead to long-term weight loss and metabolic benefits for patients.

CHIRURGIE (2023)

暂无数据